331 related articles for article (PubMed ID: 12612067)
21. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.
Wan Y; Coxe KK; Thackray VG; Housley PR; Nordeen SK
Mol Endocrinol; 2001 Jan; 15(1):17-31. PubMed ID: 11145736
[TBL] [Abstract][Full Text] [Related]
22. Cysteines 638 and 665 in the hormone binding domain of human glucocorticoid receptor define the specificity to glucocorticoids.
Yu C; Warriar N; Govindan MV
Biochemistry; 1995 Oct; 34(43):14163-73. PubMed ID: 7578014
[TBL] [Abstract][Full Text] [Related]
23. Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
Wallace AD; Cao Y; Chandramouleeswaran S; Cidlowski JA
Steroids; 2010 Dec; 75(12):1016-23. PubMed ID: 20619282
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.
Kino T; Liou SH; Charmandari E; Chrousos GP
Mol Med; 2004; 10(7-12):80-8. PubMed ID: 16307173
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants.
Nishi M; Ogawa H; Ito T; Matsuda KI; Kawata M
Mol Endocrinol; 2001 Jul; 15(7):1077-92. PubMed ID: 11435609
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid receptor dimerization in the cytoplasm might be essential for nuclear localization.
Lee SJ; Shizu R; Negishi M
Biochem Biophys Res Commun; 2021 May; 553():154-159. PubMed ID: 33773137
[TBL] [Abstract][Full Text] [Related]
28. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression.
Kodama T; Shimizu N; Yoshikawa N; Makino Y; Ouchida R; Okamoto K; Hisada T; Nakamura H; Morimoto C; Tanaka H
J Biol Chem; 2003 Aug; 278(35):33384-91. PubMed ID: 12810720
[TBL] [Abstract][Full Text] [Related]
29. Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells.
Tanaka M; Nishi M; Morimoto M; Sugimoto T; Kawata M
Endocrinology; 2003 Sep; 144(9):4070-9. PubMed ID: 12933681
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
32. Optical probes to identify the glucocorticoid receptor ligands in living cells.
Awais M; Sato M; Umezawa Y
Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
[TBL] [Abstract][Full Text] [Related]
33. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
34. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function.
Oakley RH; Sar M; Cidlowski JA
J Biol Chem; 1996 Apr; 271(16):9550-9. PubMed ID: 8621628
[TBL] [Abstract][Full Text] [Related]
35. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
Stenoien DL; Patel K; Mancini MG; Dutertre M; Smith CL; O'Malley BW; Mancini MA
Nat Cell Biol; 2001 Jan; 3(1):15-23. PubMed ID: 11146621
[TBL] [Abstract][Full Text] [Related]
36. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
Sarlis NJ; Bayly SF; Szapary D; Simons SS
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
[TBL] [Abstract][Full Text] [Related]
37. A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor.
Brocard J; Feil R; Chambon P; Metzger D
Nucleic Acids Res; 1998 Sep; 26(17):4086-90. PubMed ID: 9705523
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
Bamberger CM; Wald M; Bamberger AM; Schulte HM
Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity.
Wang X; Pongrac JL; DeFranco DB
Mol Endocrinol; 2002 Sep; 16(9):1987-98. PubMed ID: 12198236
[TBL] [Abstract][Full Text] [Related]
40. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
